Creatinine-to-cystatin C ratio as muscle assessment tool and predictive value for mortality and sarcopenia in patients with chronic kidney disease: a meta-analysis
BackgroundThe creatinine-to-cystatin C ratio (CCR) has been developed as a novel biomarker of sarcopenia and prognostic evaluation in various hospitalized populations. However, evidence supporting the use of CCR in patients with chronic kidney disease (CKD) remains limited. Thus, we aimed to evaluat...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2025-11-01
|
| Серія: | Frontiers in Nutrition |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/fnut.2025.1655488/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|